2022
DOI: 10.5858/arpa.2021-0205-hp
|View full text |Cite
|
Sign up to set email alerts
|

Report of a Case With Clinical and Pathologic Features of Castleman Disease That Predates Castleman's Report by More Than 50 Years

Abstract: Context.— In 1954, Benjamin Castleman, MD, described what was then believed to be a new entity in lymph node pathology. Initially labeled “Hyperplasia of the mediastinal node” and then “Localized mediastinal lymph node hyperplasia resembling thymoma,” we now recognize the condition with the eponym “Castleman disease.” We document a paper that describes the same condition, a half century before Castleman did. Objective.— To re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…Castleman disease exhibits pathognomonic features that usually allow a clear distinction from thymoma, including the micronodular variant of spindle cell thymoma with prominent B‐cell lymphoid hyperplasia 2 . Interestingly, it was recently discovered that pathognomonic Castleman features were also described by Dr. LeCount, a pathologist at Rush Medical College, over 50 years prior to the work of Castleman and colleagues 3,4 . Castleman disease and thymoma are exceedingly rare, and both share an association with autoimmune or inflammatory conditions.…”
Section: Imagementioning
confidence: 99%
See 1 more Smart Citation
“…Castleman disease exhibits pathognomonic features that usually allow a clear distinction from thymoma, including the micronodular variant of spindle cell thymoma with prominent B‐cell lymphoid hyperplasia 2 . Interestingly, it was recently discovered that pathognomonic Castleman features were also described by Dr. LeCount, a pathologist at Rush Medical College, over 50 years prior to the work of Castleman and colleagues 3,4 . Castleman disease and thymoma are exceedingly rare, and both share an association with autoimmune or inflammatory conditions.…”
Section: Imagementioning
confidence: 99%
“…2 Interestingly, it was recently discovered that pathognomonic Castleman features were also described by Dr. LeCount, a pathologist at Rush Medical College, over 50 years prior to the work of Castleman and colleagues. 3,4 Castleman disease and thymoma are exceedingly rare, and both share an association with autoimmune or inflammatory conditions. Castleman disease is a heterogeneous group of lymphoproliferative disorders with a wide spectrum of clinical presentations and outcomes.…”
mentioning
confidence: 99%
“…The second most common site is the neck and abdomen regions. The salivary gland [5,6], especially the parotid gland, is rarely affected by the disorder. The main pathological manifestation of CD is hyperplasia of small vascular-like tissues and lymphoid tissues.…”
mentioning
confidence: 99%